A first-in-human study of a novel monoclonal antibody INCSHR01210 directed against programmed cell death protein 1 (PD-1) in patients with advanced or metastatic cancer

J. Lickliter, Hui K. Gan, B. Gao, P. Grimison, J. Zou, H. Kallender, K. Sun, X. Chen, A. Behren, P. Fernandez-Penas, A. Nagrial, M. Voskoboynik, K. Woods, M. Millward, T. Meniawy

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - Sept 2017
Externally publishedYes
Event42nd European-Society-for-Medical-Oncology Congress (ESMO) - Madrid, Spain
Duration: 8 Sept 201712 Sept 2017

Cite this